Akums Drugs and Pharmaceuticals IPO Details: Akums Drugs and Pharmaceuticals IPO date is fixed, the IPO is to hit the market on July 30, 2024 and will close on August 1, 2024. Akums Drugs and Pharmaceuticals IPO to raise around ₹1,856.74 crores via IPO that comprises fresh issue of ₹680.00 crores and offer for sale up to 17,330,435 equity shares of ₹2 each. The retail quota is 10%, QIB is 75%, and HNI is 15%.
Established in 2004, Akums Drugs and Pharmaceuticals is a pharmaceutical contract development and manufacturing organization (“CDMO”) offering a comprehensive range of pharmaceutical products and services in India and overseas. As one of the leading CDMOs in India, they own the intellectual property for the manufacturing processes of several of their formulations, and their core business is focused on providing end-to-end product development and manufacturing solutions to their clients. Some of their other services include formulation research and development (“R&D”), preparation and filing of regulatory dossiers in the Indian and global markets, and other testing services. In addition to its core CDMO business, they are also engaged in the manufacturing and sale of branded pharmaceutical formulations and active pharmaceutical ingredients (“APIs”).
They are the largest India-focused CDMO in terms of revenue, production capacity and clients served during the Financial Year 2023 (among CDMOs assessed by F&S) (Source: F&S Report). As a CDMO, they produce an extensive range of dosage forms including tablets, capsules, liquid orals, vials, ampoules, blow-filled seals, topical preparations, eye drops, dry powder injections, and gummies, among others (Source: F&S Report). During the Financial Year 2024, they had a market share of 30.2% of the Indian domestic CDMO market by value, which increased from 26.7% during the Financial Year 2021 (Source: F&S Report).
Objects of the Issue
- Repayment/ prepayment of indebtedness of the company and its Subsidiaries;
- Funding incremental working capital requirements of the company;
- Pursuing inorganic growth initiatives through acquisitions; and
- General corporate purposes.
Akums Drugs and Pharmaceuticals IPO Review (Apply or Not)
- To be updated soon
Brokerage Firm IPO Review
- Capital Market: To be updated soon
- Religare Broking: To be updated soon
- Hem Securities: To be updated soon
- Arihant Capital: To be updated soon
Akums Drugs and Pharmaceuticals IPO Date & Price Band Details
| IPO Open: | July 30, 2024 |
| IPO Close: | August 1, 2024 |
| IPO Size: | Approx ₹1856.74 Crores, 27,345,162 Equity Share |
| Fresh Issue: | Approx ₹680.00 Crores, 10,014,727 Equity Share |
| Offer for Sale: | Approx ₹1262.83 Crores, 17,330,435 Equity Share |
| Face Value: | ₹2 Per Equity Share |
| IPO Price Band: | ₹646 to ₹679 Per Share |
| IPO Listing on: | BSE & NSE |
| Retail Quota: | 10% |
| QIB Quota: | 75% |
| NII Quota: | 15% |
| Discount: | N/A |
| DRHP Draft Prospectus: | Click Here |
| RHP Draft Prospectus: | Click Here |
| Anchor Investors List: | Click Here |
Akums Drugs and Pharmaceuticals IPO Market Lot
The Akums Drugs and Pharmaceuticals IPO minimum market lot is 22 shares with ₹14,938 application amount. The retail investors can apply up-to 13 lots with 286 shares or ₹194,194 amount.
| Application | Lot Size | Shares | Amount |
| Retail Minimum | 1 | 22 | ₹14,938 |
| Retail Maximum | 13 | 286 | ₹194,194 |
| S-HNI Minimum | 14 | 308 | ₹209,132 |
| B-HNI Minimum | 67 | 1474 | ₹1,000,846 |
Akums Drugs and Pharmaceuticals IPO Allotment & Listing Dates
The Akums Drugs and Pharmaceuticals IPO date is July 30 and the close date is August 1. The Akums Drugs and Pharmaceuticals IPO allotment will be finalized on August 2 and the IPO listing on August 6.
| IPO Open Date: | July 30, 2024 |
| IPO Close Date: | August 1, 2024 |
| Basis of Allotment: | August 2, 2024 |
| Refunds: | August 5, 2024 |
| Credit to Demat Account: | August 5, 2024 |
| IPO Listing Date: | August 6, 2024 |
You can check IPO subscription status and IPO allotment status on their respective pages.
Akums Drugs and Pharmaceuticals IPO Form
How to apply for the Akums Drugs and Pharmaceuticals IPO? You can apply for Akums Drugs and Pharmaceuticals IPO via ASBA available in your bank account. Just go to the online bank login and apply via your bank account by selecting the Akums Drugs and Pharmaceuticals IPO in the Invest section. The other option is you can apply for Akums Drugs and Pharmaceuticals IPO via IPO forms downloaded via NSE and BSE. Check out the Akums Drugs and Pharmaceuticals forms – Click BSE Forms & NSE Forms blank IPO forms download, fill, and submit in your bank or with your broker.
Akums Drugs and Pharmaceuticals Company Financial Report
| ₹ in Crores | |||
| Year | Revenue | Expense | PAT |
| 2022 | ₹3694.52 | ₹3874.95 | ₹250.87 |
| 2023 | ₹3700.93 | ₹3475.93 | ₹97.82 |
| 2024 | ₹4212.21 | ₹4231.45 | ₹0.79 |
Akums Drugs and Pharmaceuticals IPO Valuation – FY2024
Check Akums Drugs and Pharmaceuticals IPO valuations detail like Earning Per Share (EPS), Price/Earning P/E Ratio, Return on Net Worth (RoNW), and Net Asset Value (NAV) details.
| Earning Per Share (EPS): | ₹-0.28 per Equity Share |
| Price/Earning P/E Ratio: | N/A |
| Return on Net Worth (RoNW): | -0.57% |
| Net Asset Value (NAV): | ₹49.59 per Equity Share |
Peer Group
- Divi’s Laboratories
- Suven Pharma
- Gland Pharma
- Torrent Pharma
- Alkem Laboratories
- Eris Lifesciences
- JB Chemicals
- Mankind Pharma
- Innova Captab
Company Promoters
- Sanjeev Jain
- Sandeep Jain
- Akums Master Trust
Akums Drugs and Pharmaceuticals IPO Registrar
Link Intime India Private Ltd
Phone: +91-22-4918 6270
Email: Signatureglobal.ipo@linkintime.co.in
Website: https://linkintime.co.in/
Akums Drugs and Pharmaceuticals IPO Allotment Status Check
Check Akums Drugs and Pharmaceuticals IPO allotment status on Linkintime website allotment URL. Click Here
Akums Drugs and Pharmaceuticals IPO Lead Managers aka Merchant Bankers
- ICICI Securities Limited
- Axis Bank Limited
- Citigroup Global Markets India Private Limited
- Ambit Private Limited
Company Address
Akums Drugs and Pharmaceuticals Limited
304, Mohan Place,
LSC Saraswati Vihar,
Delhi – 110 034
Phone: +91 11 6904 1000
Email: cs@akums.net
Website: http://www.akums.in/
Akums Drugs and Pharmaceuticals IPO FAQs
What is Akums Drugs and Pharmaceuticals IPO?
Akums Drugs and Pharmaceuticals IPO is a main-board IPO. They are going to raise ₹1856.74 Crores via IPO. The issue is priced at ₹646 to ₹679 pr equity share. The IPO is to be listed on BSE & NSE.
When Akums Drugs and Pharmaceuticals IPO will open?
The IPO is to open on July 30 for QIB, NII, and Retail Investors.
What is Akums Drugs and Pharmaceuticals IPO Investors Portion?
The investors’ portion for QIB is 75%, NII is 15%, and Retail is 10%.
How to Apply the Akums Drugs and Pharmaceuticals IPO?
You can apply for Akums Drugs and Pharmaceuticals IPO via ASBA online via your bank account. You can also apply for ASBA online via UPI through your stock brokers. You can also apply via your stock brokers by filling up the offline form.
